NEW YORK (GenomeWeb News) – Molecular diagnostics firm Gene Security Network has closed a $6 million Series B round of financing, the Redwood City, Calif.-based firm said today.
The company is developing its Parental Support technology, which uses data informatics to deliver single-cell testing for chromosome abnormalities and genetic diseases. GSN also operates a CLIA-certified lab in California, providing testing services to help guide physicians in selecting embryos during in vitro fertilization.
“Our technology will enable a host of services that make genetic information actionable, so that doctors worldwide can order tests to improve the quality of life for their patients,” GSN President and CEO Matthew Rabinowitz said in a statement.
The firm’s existing investors, Claremont Creek Ventures and Sequoia Capital, participated in the round of financing along with new investor Alafi Capital.